Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins B Wollscheid, D Bausch-Fluck, C Henderson, R O'brien, M Bibel, ... Nature biotechnology 27 (4), 378-386, 2009 | 611 | 2009 |
Targeted proteomic strategy for clinical biomarker discovery R Schiess, B Wollscheid, R Aebersold Molecular oncology 3 (1), 33-44, 2009 | 444 | 2009 |
A mass spectrometric-derived cell surface protein atlas D Bausch-Fluck, A Hofmann, T Bock, AP Frei, F Cerciello, A Jacobs, ... PloS one 10 (4), e0121314, 2015 | 438 | 2015 |
On the development of plasma protein biomarkers S Surinova, R Schiess, R Hüttenhain, F Cerciello, B Wollscheid, ... Journal of proteome research 10 (1), 5-16, 2011 | 393 | 2011 |
PASSEL: The P eptide A tlas SRM experiment library T Farrah, EW Deutsch, R Kreisberg, Z Sun, DS Campbell, L Mendoza, ... Proteomics 12 (8), 1170-1175, 2012 | 240 | 2012 |
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer I Cima, R Schiess, P Wild, M Kaelin, P Schüffler, V Lange, P Picotti, ... Proceedings of the National Academy of Sciences 108 (8), 3342-3347, 2011 | 227 | 2011 |
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ... European urology 64 (1), 150-158, 2013 | 145 | 2013 |
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09) C Rothermundt, S Hayoz, AJ Templeton, R Winterhalder, RT Strebel, ... European urology 66 (3), 468-474, 2014 | 139 | 2014 |
Analysis of Cell Surface Proteome Changes via Label-free, Quantitative Mass Spectrometry* S R Schiess, LN Mueller, A Schmidt, M Mueller, B Wollscheid, R Aebersold Molecular & cellular proteomics 8 (4), 624-638, 2009 | 108 | 2009 |
A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair K Sato, E Sundaramoorthy, E Rajendra, H Hattori, AD Jeyasekharan, ... Current biology 22 (18), 1659-1666, 2012 | 74 | 2012 |
Direct selection of antibodies from complex libraries with the protein fragment complementation assay H Koch, N Gräfe, R Schiess, A Plückthun Journal of molecular biology 357 (2), 427-441, 2006 | 71 | 2006 |
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07) R Cathomas, C Rothermundt, D Klingbiel, L Bubendorf, R Jaggi, ... Clinical cancer research 18 (21), 6049-6057, 2012 | 61 | 2012 |
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome M Kälin, I Cima, R Schiess, N Fankhauser, T Powles, P Wild, A Templeton, ... European urology 60 (6), 1235-1243, 2011 | 58 | 2011 |
N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications R Huettenhain, S Surinova, R Ossola, Z Sun, D Campbell, F Cerciello, ... Molecular & Cellular Proteomics 12 (4), 1005-1016, 2013 | 57 | 2013 |
Defining potentially conserved RNA regulons of homologous zinc-finger RNA-binding proteins T Scherrer, C Femmer, R Schiess, R Aebersold, AP Gerber Genome biology 12, 1-19, 2011 | 49 | 2011 |
Similarities and differences of blood N-glycoproteins in five solid carcinomas at localized clinical stage analyzed by SWATH-MS T Sajic, Y Liu, E Arvaniti, S Surinova, EG Williams, R Schiess, ... Cell reports 23 (9), 2819-2831. e5, 2018 | 43 | 2018 |
Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets C Danzer, K Eckhardt, A Schmidt, N Fankhauser, S Ribrioux, ... Journal of proteome research 11 (3), 1598-1608, 2012 | 42 | 2012 |
Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer H Klocker, B Golding, S Weber, E Steiner, P Tennstedt, T Keller, ... BJUI compass 1 (1), 15-20, 2020 | 30 | 2020 |
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies T Steuber, P Tennstedt, A Macagno, A Athanasiou, A Wittig, R Huber, ... BJU international 123 (5), 826-833, 2019 | 27 | 2019 |
Biomarker Validation in Blood Specimens by Selected Reaction Monitoring Mass Spectrometry of N-Glycosites R Ossola, R Schiess, P Picotti, O Rinner, L Reiter, R Aebersold Serum/plasma proteomics: methods and protocols, 179-194, 2011 | 27 | 2011 |